Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach

Overview of attention for article published in Drug Design, Development and Therapy, July 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

twitter: 2 X users
patent: 3 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 94 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,810 followers.

Review: Development of oral agent in the treatment of #MS: how the first available oral therapy, fingolimod will... http://t.co/dNd7bjFG

Reply Repost Favourite

Fingolimod for treatment of multiple sclerosis http://t.co/J8AZGqvg #dovepress

Reply Repost Favourite